Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

XOMA Corp

XOMA
Current price
26.71 USD +1.14 USD (+4.46%)
Last closed 25.40 USD
ISIN US98419J2069
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 327 794 720 USD
Yield for 12 month +35.24 %
1Y
3Y
5Y
10Y
15Y
XOMA
21.11.2021 - 28.11.2021

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California. Address: 2200 Powell Street, EmeryVille, CA, United States, 94608

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

89.00 USD

P/E ratio

Dividend Yield

Current Year

+4 758 000 USD

Last Year

+6 027 000 USD

Current Quarter

+7 197 000 USD

Last Quarter

+11 086 000 USD

Current Year

+3 861 000 USD

Last Year

+5 930 000 USD

Current Quarter

+7 197 000 USD

Last Quarter

+11 083 000 USD

Key Figures XOMA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -15 171 000 USD
Operating Margin TTM -22.79 %
PE Ratio
Return On Assets TTM -5.54 %
PEG Ratio -0.42
Return On Equity TTM -31.41 %
Wall Street Target Price 89.00 USD
Revenue TTM 21 606 000 USD
Book Value 7.21 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 767.10 %
Dividend Yield
Gross Profit TTM 5 874 000 USD
Earnings per share -3.15 USD
Diluted Eps TTM -3.15 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY 37.00 %
Profit Margin -138.67 %

Dividend Analytics XOMA

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History XOMA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 02.04.2024
Forward Annual Dividend Yield
Last Split Factor 1:20
Payout Ratio
Last Split Date 18.10.2016
Dividend Date 18.10.2016

Stock Valuation XOMA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 158.73
Enterprise Value Revenue 30.49
Price Sales TTM 15.17
Enterprise Value EBITDA -6.91
Price Book MRQ 3.77

Financials XOMA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators XOMA

For 52 weeks

17.52 USD 35.00 USD
50 Day MA 29.94 USD
Shares Short Prior Month 130 424
200 Day MA 26.92 USD
Short Ratio 3.33
Shares Short 112 554
Short Percent 1.39 %